Thrombin-Activatable Fibrinolysis Inhibitor and Cardiovascular Risk Factors in Polycystic Ovary Syndrome

2008 ◽  
Vol 116 (03) ◽  
pp. 143-147 ◽  
Author(s):  
M. Erdoğan ◽  
M. Karadeniz ◽  
G. Alper ◽  
S. Tamsel ◽  
H. Uluer ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Polycystic Ovary Syndrome ◽  
Cardiovascular Risk Factors ◽  
Polycystic Ovary ◽  
Thrombin Activatable Fibrinolysis Inhibitor ◽  
Ovary Syndrome ◽  
Fibrinolysis Inhibitor

Cardiovascular risk factors in polycystic ovary syndrome

2005 ◽  
Vol 113 (S 1) ◽  
Author(s):  
S Tan ◽  
S Hahn ◽  
K Pleger ◽  
S Sack ◽  
BL Herrmann ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Polycystic Ovary Syndrome ◽  
Cardiovascular Risk Factors ◽  
Polycystic Ovary ◽  
Ovary Syndrome

Association of polycystic ovary syndrome with cardiovascular risk factors

2009 ◽  
pp. 1-7
Author(s):  
Tanzeela Akram ◽  
Shahid Hasan ◽  
Muhammad Imran ◽  
Asima Karim ◽  
Muhammad Arslan
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Polycystic Ovary Syndrome ◽  
Cardiovascular Risk Factors ◽  
Polycystic Ovary ◽  
Ovary Syndrome

Cardiovascular risk factors are reduced with a low dose of acarbose in obese patients with polycystic ovary syndrome

2007 ◽  
Vol 88 (2) ◽  
pp. 519-522 ◽  
Author(s):  
Ivan Araujo Penna ◽  
Paulo Roberto Bastos Canella ◽  
Carolina Sales Vieira ◽  
Marcos Felipe Silva de Sá ◽  
Rosana Maria dos Reis ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Polycystic Ovary Syndrome ◽  
Cardiovascular Risk Factors ◽  
Low Dose ◽  
Polycystic Ovary ◽  
Obese Patients ◽  
Ovary Syndrome
Sign in / Sign up

Export Citation Format

Share Document